1. Home
  2. LXFR vs CMPX Comparison

LXFR vs CMPX Comparison

Compare LXFR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXFR
  • CMPX
  • Stock Information
  • Founded
  • LXFR 1898
  • CMPX 2014
  • Country
  • LXFR United States
  • CMPX United States
  • Employees
  • LXFR N/A
  • CMPX N/A
  • Industry
  • LXFR Major Chemicals
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXFR Industrials
  • CMPX Health Care
  • Exchange
  • LXFR Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • LXFR 274.4M
  • CMPX 229.5M
  • IPO Year
  • LXFR 2012
  • CMPX N/A
  • Fundamental
  • Price
  • LXFR $9.84
  • CMPX $1.96
  • Analyst Decision
  • LXFR
  • CMPX Strong Buy
  • Analyst Count
  • LXFR 0
  • CMPX 8
  • Target Price
  • LXFR N/A
  • CMPX $13.57
  • AVG Volume (30 Days)
  • LXFR 128.2K
  • CMPX 2.7M
  • Earning Date
  • LXFR 04-29-2025
  • CMPX 05-12-2025
  • Dividend Yield
  • LXFR 5.26%
  • CMPX N/A
  • EPS Growth
  • LXFR N/A
  • CMPX N/A
  • EPS
  • LXFR 0.68
  • CMPX N/A
  • Revenue
  • LXFR $391,900,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • LXFR $2.26
  • CMPX $47.65
  • Revenue Next Year
  • LXFR $5.85
  • CMPX $2,767.57
  • P/E Ratio
  • LXFR $14.45
  • CMPX N/A
  • Revenue Growth
  • LXFR N/A
  • CMPX N/A
  • 52 Week Low
  • LXFR $9.38
  • CMPX $0.77
  • 52 Week High
  • LXFR $15.64
  • CMPX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • LXFR 34.96
  • CMPX 42.73
  • Support Level
  • LXFR $9.41
  • CMPX $1.60
  • Resistance Level
  • LXFR $10.80
  • CMPX $1.78
  • Average True Range (ATR)
  • LXFR 0.59
  • CMPX 0.27
  • MACD
  • LXFR -0.01
  • CMPX 0.04
  • Stochastic Oscillator
  • LXFR 18.22
  • CMPX 40.72

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: